BeStock  
Stocks › Medical Devices › BRKR

Bruker Corp BRKR

US equityMarket cap rank #1533Medical DevicesRoom-Temp Superconductors
$56.46 −$5.64 (-9.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.46 0.00%
Open$60.65
Prev close$62.10
Day range$56.13 – $61.10
Volume2.25M
Market cap$8.62B
P/E (TTM)–
Dividend yield0.35%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership95.3%+0.15 pts vs. prior quarter
Institutions holding509+13 vs. prior quarter
Insider trades (recent)26 buys / 23 sellsNet buying
Short interest7.38% of floatDays to cover 5.4 · as of 30 Oct 2026
Short-sale volume share22.7%5-day average of daily volume

Short-sale volume as % of daily volume

7%17%28%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$92.99M (4 inflow days, 16 outflow days).

Net flow by order size, last 20 sessions

−$75.8MSuper−$17.1MBig−$17.6MMid+$3.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 62.1% of shares outstanding.

Largest holders

  • Frank Laukien26.47%
  • Orbis Investment Management Limited11.75%
  • FMR9.94%
  • BlackRock7.72%
  • Pallas Capital Advisors LLC6.21%
  • Joerg Laukien4.92%
  • Strategic Advisers LLC3.35%
  • Vanguard Portfolio Management, LLC3.26%

By investor type

  • Mutual Fund77.06%
  • Individual/Insider31.82%
  • Hedge Fund11.29%
  • Public Company3.11%
  • Government Pension Fund2.46%
  • Private Company0.83%
  • Sovereign Wealth Fund0.25%
  • Insurance Company0.14%

Reported short interest has fallen from 7.74% to 7.38% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Barrow, Hanley, Mewhinney & Strauss, LLC Mutual Fund 2026/Q3 +1,014,293 0.7%
BlackRock Mutual Fund 2026/Q3 +382,104 7.7%
Brooklands Fund Management Limited Hedge Fund 2026/Q3 +309,800 0.2%
FMR Mutual Fund 2026/Q3 +245,109 9.9%
Barclays PLC Public Company 2026/Q3 +155,489 0.2%
Tairen Capital Limited Hedge Fund 2026/Q3 +130,000 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +131,798 0.1%
FMR Mutual Fund 2026/Q3 +3,594,691 9.8%
Sachem Head Capital Management LP Hedge Fund 2026/Q3 +2,915,000 1.9%
Sculptor Capital Management, Inc. Hedge Fund 2026/Q3 +1,355,000 3.0%
AQR Capital Management Hedge Fund 2026/Q3 +1,211,173 1.6%
Viking Global Investors LP Hedge Fund 2026/Q3 +893,491 0.6%
Steadfast Capital Management LP Hedge Fund 2026/Q3 +654,700 0.4%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +653,007 0.9%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +572,931 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Sep 2026 Mark Munch Corporate Executive VP & President of Bruker Nano Group Derivative Exercise and Sale -2,000 $52.87 92,026
16 Aug 2026 Wolfgang Pusch Open Market Disposition -3,473 $56.90 6,681
14 Aug 2026 Frank Laukien Chairperson & CEO Sale to Issuer -4,760 $57.70 40,421,551
14 Aug 2026 Frank Laukien Chairperson & CEO Other Acquisition +29,463 – 89,570
14 Aug 2026 Frank Laukien Chairperson & CEO Other Derivative Acquisition +71,651 $63.47 71,651
14 Aug 2026 Mark Munch Corporate Executive VP & President of Bruker Nano Group Sale to Issuer -2,984 $57.70 92,026
14 Aug 2026 Mark Munch Corporate Executive VP & President of Bruker Nano Group Other Acquisition +14,443 – 42,780
14 Aug 2026 Mark Munch Corporate Executive VP & President of Bruker Nano Group Other Derivative Acquisition +11,708 $57.70 11,708
14 Aug 2026 Gerald Herman Chief Financial Officer Sale to Issuer -2,724 $57.70 61,062
14 Aug 2026 Gerald Herman Chief Financial Officer Other Acquisition +15,794 – 50,292
14 Aug 2026 Gerald Herman Chief Financial Officer Other Derivative Acquisition +12,803 $63.47 12,803
14 Aug 2026 Burkhard Prause President and CEO of Bruker Energy & Supercon Technologies, Inc. Other Acquisition +3,303 – 9,267
14 Aug 2026 Burkhard Prause President and CEO of Bruker Energy & Supercon Technologies, Inc. Other Derivative Acquisition +2,678 $57.70 2,678
14 Aug 2026 Juergen Srega President of Bruker Biosystems Group & Bruker Daltonics Division Other Acquisition +16,898 – 29,040
14 Aug 2026 Juergen Srega President of Bruker Biosystems Group & Bruker Daltonics Division Other Derivative Acquisition +13,698 $57.70 13,698
14 Aug 2026 Thomas Bures Chief Accounting Officer Other Acquisition +4,035 – 6,264
14 Aug 2026 Wolfgang Pusch Other Acquisition +3,120 – 3,120
14 Aug 2026 Wolfgang Pusch Other Derivative Acquisition +2,529 $57.70 2,529
13 Aug 2026 Mark Munch Corporate Executive VP & President of Bruker Nano Group Derivative Exercise and Sale -2,000 $57.60 92,026
10 Aug 2026 Frank Laukien Chairperson & CEO Sale to Issuer -4,838 $57.02 40,414,203

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 11,251,178 7.4% 5.4
15 Oct 2026 12,673,281 8.3% 5.7
30 Sep 2026 12,406,174 8.1% 5.1
15 Sep 2026 12,490,387 8.2% 6.3
31 Aug 2026 12,005,384 7.9% 6.3
14 Aug 2026 11,785,398 7.7% 4.0

Discussion

No comments yet — be the first to weigh in on BRKR.

Sign in to join the discussion.

Scroll to Top